Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, McCracken M, Mulvey MR, Johnson J; Canadian Antimicrobial Resistance Alliance (CARA); Hoban DJ. Zhanel GG, et al. Among authors: walkty a. Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7. doi: 10.1128/AAC.01538-07. Epub 2008 Feb 19. Antimicrob Agents Chemother. 2008. PMID: 18285482 Free PMC article.
Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
Walkty A, Decorby M, Nichol K, Mulvey MR, Hoban D, Zhanel G; Canadian Antimicrobial Resistance Alliance. Walkty A, et al. Diagn Microbiol Infect Dis. 2008 Jun;61(2):217-21. doi: 10.1016/j.diagmicrobio.2008.01.009. Epub 2008 Mar 4. Diagn Microbiol Infect Dis. 2008. PMID: 18304774
In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study.
Walkty A, Decorby M, Nichol K, Karlowsky JA, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA). Walkty A, et al. J Antimicrob Chemother. 2008 Jul;62(1):206-8. doi: 10.1093/jac/dkn140. Epub 2008 Apr 1. J Antimicrob Chemother. 2008. PMID: 18385143 No abstract available.
Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, Mulvey MR, Hoban DJ; Canadian Antimicrobial Resistance Alliance. Zhanel GG, et al. Among authors: walkty a. Diagn Microbiol Infect Dis. 2008 Sep;62(1):67-80. doi: 10.1016/j.diagmicrobio.2008.04.012. Epub 2008 May 29. Diagn Microbiol Infect Dis. 2008. PMID: 18513913
Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG, Lam A, Schweizer F, Thomson K, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Noreddin AM, Karlowsky JA. Zhanel GG, et al. Among authors: walkty a. Am J Clin Dermatol. 2008;9(4):245-54. doi: 10.2165/00128071-200809040-00004. Am J Clin Dermatol. 2008. PMID: 18572975 Review.
132 results